Rate My Professor Petra Rocic

Dr. Rocic's research focuses on cardiovascular physiology and pharmacology, with emphasis on the regulation of coronary collateral growth in the metabolic syndrome. She has served as principal investigator on several NIH NHLBI R01 grants, including "Regulation of Coronary Collateral Growth in the Metabolic Syndrome" (2008-2015), "Mechanistic Basis of miR-145-mediated Restoration of Coronary Collateral Growth" (2015-2020), and diversity supplements. Selected publications include "20-HETE in the regulation of vascular and cardiac function" (Pharmacology & Therapeutics, 2018), "MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome" (Arteriosclerosis, Thrombosis, and Vascular Biology, 2013), "Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction" (American Journal of Physiology - Heart and Circulatory Physiology, 2017), and "The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth" (Arteriosclerosis, Thrombosis, and Vascular Biology, 2008). With over 10 years of experience in medical education, she has directed and lectured in courses on scientific foundations, cardiovascular pharmacology, endocrine pharmacology, and medical biochemistry for medical and graduate students. Dr. Rocic has mentored numerous MD/PhD, PhD, MS, and undergraduate students to degree completion. She received the Howard Hughes Undergraduate Summer Research Scholarship (1995) and Red Sash Teaching Awards (2012, 2013), served on editorial boards for Circulation Research, American Journal of Physiology: Heart and Circulatory Physiology, and Microcirculation, and participated in NIH and AHA grant review panels. She has delivered invited presentations at conferences such as the American Heart Association Scientific Sessions and World Congress for Microcirculation.